SigVie-002 failed to improve OS with sigvotatug vedotin vs docetaxel, while a post hoc second-line analysis showed a PFS ...
Association Between HRQoL and Clinical Outcomes in Advanced RCC / cancer, cancer care, Cancer research, cancer treatment, ...
TOP-1 Study Reports 14.8% Five-Year Local Recurrence After Radiotherapy Omission in Older Women With Breast Cancer / Breast ...
Journal of Breakthroughs in Immuno-Oncology Launches With New Editorial Board / Alex A. Adjei, cancer, David J. Kerr, Dégi ...
Building Better Childhood Cancer Care Through Data and Research / cancer, Childhood Cancer, Cyprus Childhood Cancer ...
Final Analysis of Adjuvant Pembrolizumab in Clear Cell RCC / cancer, cancer care, Cancer research, cancer treatment, Clear ...
Patient-Reported Outcomes With Adjuvant Durvalumab in Resected RCC / cancer, cancer care, Cancer research, cancer treatment, ...
What Can We Achieve Together in the Fight Against Cancer? - AORTIC- Africa / AORTIC, AORTIC Africa, Breast Cancer, cancer, cervical cancer, OncoDaily, ...
For more than four decades, Alberto Costa helped transform Umberto Veronesi’s vision into the European School of Oncology (ESO), connecting generations of cancer professionals through education, ...
VOLGA at ESMO 2026: Perioperative Durvalumab With or Without Tremelimumab Plus Enfortumab Vedotin in MIBC ...
VOLGA at ESMO 2026: Perioperative Durvalumab With or Without Tremelimumab Plus Enfortumab Vedotin in MIBC ...
COCOON shows lazertinib lead-in plus simplified prophylaxis reduced grade ≥2 skin toxicity to 18% with SC amivantamab in EGFR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results